N
Nan Lin
Researcher at Harvard University
Publications - 1220
Citations - 65601
Nan Lin is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Breast cancer. The author has an hindex of 105, co-authored 687 publications receiving 54545 citations. Previous affiliations of Nan Lin include University of Michigan & Fujian Medical University.
Papers
More filters
Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol. 7: Care Coordination)
Kathryn M. McDonald,Vandana Sundaram,Dena M. Bravata,Robyn Lewis,Nan Lin,Sally A Kraft,Moira C McKinnon,Helen Paguntalan,Douglas K Owens +8 more
TL;DR: A working definition of care coordination is developed, applied to a review of systematic reviews, and theoretical frameworks that might predict or explain how care coordination mechanisms are influenced by factors in the health care setting and how they relate to patient outcomes and health care costs are identified.
Book ChapterDOI
Inequality in Social Capital
TL;DR: In this article, a critical issue in social capital research is examined, which is the extent to which social capital is unequally distributed across social groups in a community or population, and the authors consider some general issues and approaches to the analysis of inequality in all types of capital.
Journal ArticleDOI
Response assessment criteria for brain metastases: proposal from the RANO group
Nan Lin,Eudocia Q. Lee,Hidefumi Aoyama,Igor J. Barani,Daniel P. Barboriak,Brigitta G. Baumert,Martin Bendszus,Paul D. Brown,D. Ross Camidge,Susan M. Chang,Janet Dancey,Elisabeth G.E. de Vries,Laurie E. Gaspar,Gordon J. Harris,F. Stephen Hodi,Steven N. Kalkanis,Mark E. Linskey,Mark E. Linskey,David R. Macdonald,Kim Margolin,Minesh P. Mehta,David Schiff,Riccardo Soffietti,John H. Suh,Martin J. van den Bent,Michael A. Vogelbaum,Patrick Y. Wen +26 more
TL;DR: Recommendations for standard response and progression criteria for the assessment of brain metastases in clinical trials are presented and hopefully facilitate the development of novel approaches to this difficult problem by providing more uniformity.
Journal ArticleDOI
Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.
Nan Lin,Elizabeth B. Claus,Elizabeth B. Claus,Jessica Sohl,Abdul Rab Razzak,Amal Arnaout,Eric P. Winer +6 more
TL;DR: The purpose of the current study was to characterize the outcomes of patients with metastatic triple‐negative breast cancers, including the risk and clinical consequences of central nervous system (CNS) recurrence.
Journal ArticleDOI
Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
Nan Lin,Véronique Diéras,Devchand Paul,Dominique Lossignol,Christos Christodoulou,Hans-Joachim Stemmler,Henri Roché,Minetta C. Liu,Richard Greil,Eva Ciruelos,Sibylle Loibl,Stefania Gori,Andrew M Wardley,Denise A. Yardley,Adam Brufsky,Joanne L. Blum,Stephen D. Rubin,Bernie Dharan,Klaudia Steplewski,Denise Zembryki,Cristina Oliva,Debasish F. Roychowdhury,Paolo Paoletti,Eric P. Winer +23 more
TL;DR: This study confirms the modest CNS antitumor activity of lapatinib and adds that further studies of Lapatinib-based regimens for CNS metastases from HER2+ breast cancer are warranted.